Your browser doesn't support javascript.
loading
Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal.
Chapagain, Ram Hari; Maharjan, Jessica; Adhikari, Santosh; Thapa, Prabhat; Kunwar, Kshitij; Giri, Bishnu Rath; Shrestha, Nisha Jyoti; Shrestha, Anil Kumar; Shrestha, Sanjeet Kumar; Tamang, Suresh Man; Cho, Haeun; Park, Eun Lyeong; Lee, Jiyoung; Lee, Jinae; Kim, Deok Ryun; Yang, Jae Seung; Saluja, Tarun; Wartel, Anh; Lynch, Julia; Song, Katerina Rok.
Afiliação
  • Chapagain RH; OCV-S Trial Site, Kanti Children's Hospital, Kathmandu, Nepal.
  • Maharjan J; Department of Paediatrics, National Academy of Medical Sciences (NAMS), Kathmandu, Nepal.
  • Adhikari S; OCV-S Trial Site, Kanti Children's Hospital, Kathmandu, Nepal.
  • Thapa P; OCV-S Trial Site, Kanti Children's Hospital, Kathmandu, Nepal.
  • Kunwar K; OCV-S Trial Site, Kanti Children's Hospital, Kathmandu, Nepal.
  • Giri BR; OCV-S Trial Site, Kanti Children's Hospital, Kathmandu, Nepal.
  • Shrestha NJ; OCV-S Trial Site, Kanti Children's Hospital, Kathmandu, Nepal.
  • Shrestha AK; OCV-S Trial Site, Kanti Children's Hospital, Kathmandu, Nepal.
  • Shrestha SK; Department of Paediatrics, National Academy of Medical Sciences (NAMS), Kathmandu, Nepal.
  • Tamang SM; OCV-S Trial Site, Kanti Children's Hospital, Kathmandu, Nepal.
  • Cho H; Department of Paediatrics, National Academy of Medical Sciences (NAMS), Kathmandu, Nepal.
  • Park EL; OCV-S Trial Site, Kanti Children's Hospital, Kathmandu, Nepal.
  • Lee J; OCV-S Trial Site, Kanti Children's Hospital, Kathmandu, Nepal.
  • Lee J; Biostatistics & Data Management Unit, International Vaccine Institute (IVI), Seoul, Korea.
  • Kim DR; Biostatistics & Data Management Unit, International Vaccine Institute (IVI), Seoul, Korea.
  • Yang JS; Biostatistics & Data Management Unit, International Vaccine Institute (IVI), Seoul, Korea.
  • Saluja T; Biostatistics & Data Management Unit, International Vaccine Institute (IVI), Seoul, Korea.
  • Wartel A; Biostatistics & Data Management Unit, International Vaccine Institute (IVI), Seoul, Korea.
  • Lynch J; Science Unit, International Vaccine Institute (IVI), Seoul, Korea.
  • Song KR; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute (IVI), Seoul, Korea.
Hum Vaccin Immunother ; 19(2): 2239680, 2023 08 01.
Article em En | MEDLINE | ID: mdl-37539816
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Guideline Limite: Child / Humans País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Guideline Limite: Child / Humans País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article